Fundraising FoxDRI Healthcare
Venture debtToronto · 40 people tracked
Find your way into DRI Healthcare
Sign up to see every warm intro you have to DRI Healthcare
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DRI Healthcare team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
DRI Healthcare specializes in pharmaceutical royalty monetization, acquiring dependable, patent-protected cash flow streams derived from sales of important drugs across multiple therapeutic areas. The firm positions itself as a partner for both investors and innovators, offering creative and flexible deal structures tailored to counterparty needs, and works with multiple repeat deal partners. Its strategy centers on acquiring interests in medicines that effectively treat and address unmet medical needs, functioning as a smart capital allocator building a diversified royalty portfolio.
Source: firm website, verified Aug 3, 2026.
Team · 40 people
from the firm's website & public directories
CEO of DRI Healthcare and founder and Managing Director of Toronto-based Maryana Capital. He previously co-founded Edoma Capital in London, was a partner at Indus Capital, and held senior roles at Goldman Sachs from 1997 to 2010, including Managing Director.
Alyssa Klapper is Associate General Counsel at DRI Healthcare. She is an intellectual property attorney focused on life sciences litigation and transactions.
Chair of the board for Vancouver Airport Authority and an experienced corporate director serving on multiple TSX company boards, including audit committee chair roles at Saputo and The North West Company.
Public sector leader with more than 30 years in senior roles across the Alberta and BC provincial governments and the Government of Canada; most recently President and CEO of Alberta Health Services.
Courtney Grady is a Senior Analyst in Research & Investments at DRI Healthcare, with experience in due diligence, commercialization, and product development. Her earlier career includes roles in life science consulting and the startup sector. She holds a PhD in Biomedical Sciences focused on immunology, infectious disease, and genetics, and has a background in statistics, data management, and project management.
Seasoned corporate director with roughly 20 years of board experience across multiple sectors and senior government roles. Was a Senior Adviser at Lazard Canada from 2016 to 2023 and previously President of Coastal Contacts Inc.
Leader with over 40 years in strategic planning, operations and governance in real estate and retail; President and CEO of Wesbild Holdings since 2008 and former President of Future Shop.
Healthcare executive currently CEO of Cydar Medical, an AI and cloud-based medical device company; joined Cydar as a non-executive director in 2019 before becoming CEO in 2020.
Tenured Professor of Law and Chair in Corporate Governance at Osgoode Hall Law School and a corporate lawyer/Affiliated Scholar at Davies Ward Phillips & Vineberg, with expertise in governance.
Business executive with senior leadership experience in finance, transportation, infrastructure and health; currently President and CEO of Vancouver Airport Authority.
Gordon Winston is Founder, Chairman, and CEO of QGEMS, Inc. and QSecGrid, Inc., companies developing digital energy infrastructure for distributed energy resources and critical infrastructure modernization. He previously spent 14 years in Wall Street finance and later led the evolution of Drug Royalty Corporation into DRI Capital, an IP-based investment manager with $5 billion in assets under management. Winston serves in the World Presidents' Organization and Young Presidents' Organization, and is co-founder of the Peace Innovation Initiative and Cooperative for Humanity.
What they invest in
from 1 of 1 portfolio companiesAI & Machine Learning ×1Biotech ×1Healthtech ×1
HQs:Canada×1
Investments · 1 tracked
founders shown can be your intro path
biossil is an AI-native biopharma company developing late-stage drug programs for life-threatening conditions with unmet needs, including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer's disease.
AI & Machine LearningBiotechHealthtechToronto, CA
Alexander I. Mosa(MD PhD)Anthony Mouchantaf(JD MBA)
Co-investorsFounders FundGolden VenturesPanache VenturesStaircase Ventures137 VenturesQuiet Capital
Portfolio news
latest coverage across their companiesBiossil · betakit.com · Apr 23, 2026
Frequently asked questions
- What sectors does DRI Healthcare focus on?
- DRI Healthcare focuses on Biotech, Healthtech, Medical Devices.
- Where is DRI Healthcare located?
- DRI Healthcare is headquartered in Toronto, CA.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.